Bliss GVS Pharma Ltd.
BSE: 506197 | Sector: Health care |
NSE: BLISSGVS | ISIN Code: INE416D01022 |
BSE 00:00 | 25 May | 75.20 |
4.30 (6.06%) |
OPEN
71.40 |
HIGH
76.90 |
LOW
69.60 |
NSE 00:00 | 25 May | 75.60 |
4.60 (6.48%) |
OPEN
71.00 |
HIGH
77.00 |
LOW
69.55 |
OPEN | 71.40 |
PREVIOUS CLOSE | 70.90 |
VOLUME | 28838 |
52-Week high | 128.40 |
52-Week low | 66.25 |
P/E | 8.60 |
Mkt Cap.(Rs cr) | 781 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bliss GVS Pharma Ltd. (BLISSGVS) - Yearly Result
Particulars (![]() |
Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
Net Sales/Income From Operations | 636.36 | 465.51 | 441.95 | 426.59 | 297.89 |
Other Income | 35.37 | 17.68 | 37.00 | 35.81 | 11.00 |
Total Income | 671.73 | 483.20 | 478.95 | 462.40 | 308.89 |
Total Expenditure | 527.16 | 374.05 | 341.78 | 333.49 | 209.43 |
Operating Profit | 144.57 | 109.14 | 137.17 | 128.91 | 99.46 |
Interest | 4.32 | 4.19 | 6.62 | 3.15 | 6.95 |
Gross Profit | 140.25 | 104.95 | 130.54 | 125.76 | 92.51 |
Depreciation | 13.85 | 13.76 | 8.83 | 5.75 | 5.67 |
PBT | 126.40 | 91.19 | 121.71 | 120.01 | 86.83 |
Tax | 32.97 | 22.52 | 31.91 | 45.44 | 30.20 |
Net Profit/(Loss) | 92.66 | 67.50 | 92.33 | 74.43 | 57.01 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 2.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 90.65 | 67.50 | 92.33 | 74.43 | 57.01 |
Equity Share Capital | 10.31 | 10.31 | 10.31 | 10.31 | 10.31 |
Reserves Excluding Revaluation Reserves | 841.06 | 745.33 | 672.63 | 592.96 | 531.11 |
EPS | |||||
Basic EPS | 8.97 | 6.54 | 8.95 | 7.22 | 5.53 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices